Naperol Investments Ltd
Incorporated in 1954, National Peroxide Ltd is engaged in Investment and Leasing business[1]
- Market Cap ₹ 509 Cr.
- Current Price ₹ 886
- High / Low ₹ 1,796 / 801
- Stock P/E 47.2
- Book Value ₹ 1,518
- Dividend Yield 0.11 %
- ROCE -0.04 %
- ROE -0.04 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.58 times its book value
- Company has been maintaining a healthy dividend payout of 30.4%
Cons
- The company has delivered a poor sales growth of -63.8% over past five years.
- Company has a low return on equity of 2.08% over last 3 years.
- Company has high debtors of 193 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
154 | 212 | 234 | 196 | 233 | 233 | 306 | 402 | 208 | 226 | 232 | 2 | 90 | |
107 | 146 | 173 | 174 | 197 | 163 | 161 | 175 | 166 | 170 | 209 | 2 | 71 | |
Operating Profit | 47 | 67 | 61 | 22 | 36 | 70 | 145 | 226 | 42 | 56 | 23 | -0 | 19 |
OPM % | 31% | 31% | 26% | 11% | 15% | 30% | 47% | 56% | 20% | 25% | 10% | -13% | 21% |
2 | 5 | 7 | 6 | 7 | -2 | 11 | 19 | 1 | -15 | 10 | 376 | 1 | |
Interest | 0 | 0 | 0 | 5 | 5 | 2 | 1 | 1 | 3 | 13 | 9 | -0 | 1 |
Depreciation | 10 | 11 | 10 | 7 | 9 | 9 | 9 | 9 | 11 | 18 | 17 | -0 | 5 |
Profit before tax | 39 | 60 | 58 | 16 | 29 | 57 | 146 | 235 | 29 | 12 | 7 | 376 | 14 |
Tax % | 29% | 34% | 34% | 62% | 37% | 34% | 35% | 35% | 40% | -76% | 32% | 0% | |
27 | 40 | 39 | 6 | 18 | 38 | 95 | 153 | 17 | 21 | 5 | 375 | 11 | |
EPS in Rs | 48.21 | 69.84 | 67.75 | 10.93 | 31.53 | 66.46 | 166.88 | 268.47 | 30.47 | 36.51 | 8.93 | 658.33 | 18.93 |
Dividend Payout % | 25% | 22% | 22% | 46% | 32% | 52% | 39% | 24% | 41% | 35% | 56% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -38% |
5 Years: | -64% |
3 Years: | -79% |
TTM: | -29% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 261% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | -15% |
3 Years: | -22% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 7% |
3 Years: | 2% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 143 | 172 | 201 | 203 | 214 | 368 | 503 | 609 | 481 | 583 | 532 | 552 | 859 |
5 | 1 | 4 | 73 | 30 | 11 | -0 | 80 | 161 | 125 | 94 | -0 | -0 | |
47 | 57 | 59 | 62 | 60 | 55 | 76 | 88 | 94 | 71 | 63 | 1 | 6 | |
Total Liabilities | 201 | 236 | 270 | 344 | 310 | 440 | 585 | 783 | 742 | 785 | 694 | 559 | 871 |
118 | 110 | 117 | 187 | 180 | 178 | 170 | 166 | 372 | 342 | 338 | 0 | 0 | |
CWIP | 3 | 3 | 41 | 4 | 3 | 2 | 6 | 75 | -0 | 3 | 4 | -0 | -0 |
Investments | 24 | 59 | 10 | 10 | 7 | 170 | 253 | 192 | 177 | 268 | 282 | 547 | 860 |
57 | 64 | 102 | 143 | 120 | 90 | 156 | 350 | 193 | 172 | 71 | 12 | 11 | |
Total Assets | 201 | 236 | 270 | 344 | 310 | 440 | 585 | 783 | 742 | 785 | 694 | 559 | 871 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
47 | 41 | 28 | 21 | 22 | 59 | 94 | 148 | 16 | 61 | 9 | 1 | |
-35 | -29 | -21 | -75 | 30 | -31 | -56 | -175 | -38 | -7 | 34 | 1 | |
-12 | -12 | -7 | 54 | -51 | -28 | -35 | 35 | 14 | -49 | -49 | -3 | |
Net Cash Flow | -0 | 0 | -0 | 0 | -0 | -0 | 3 | 8 | -9 | 4 | -6 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 58 | 54 | 51 | 69 | 51 | 52 | 64 | 28 | 57 | 38 | 30 | 193 |
Inventory Days | 99 | 56 | 134 | 76 | 65 | 66 | 65 | 134 | 98 | 87 | 87 | |
Days Payable | 182 | 175 | 126 | 120 | 83 | 115 | 90 | 101 | 75 | 102 | 41 | |
Cash Conversion Cycle | -25 | -64 | 59 | 25 | 33 | 4 | 39 | 61 | 80 | 23 | 76 | 193 |
Working Capital Days | 49 | 26 | 72 | 150 | 102 | 64 | 115 | 238 | 230 | 197 | 42 | -85 |
ROCE % | 27% | 37% | 30% | 9% | 13% | 21% | 33% | 39% | 5% | 6% | 1% | -0% |
Documents
Announcements
- Board Meeting Intimation for Declaration Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2024. 15h
-
Announcement under Regulation 30 (LODR)-Change in Management
2d - Mr. Shailesh Sawant, Chief Financial Officer & Chief Risk Officer (CFO & CRO) of the Company, has given a notice of resignation from the post …
- Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2024 25 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Certificate under Regulation 74(5) of SEBI (DP) Regulations as received from RTA.
- Compliance Certificate For The Year Ended March 31, 2024 15 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Services Offered:[1]
a) Manufacturing, distribution and dealing
of peroxygen chemicals
b) Making long term investments and corporate lending directly and/or through its wholly owned subsidiary viz., the Transferor Company.